Press release
Fungal Antigens Market Segmentation By product type Aspergillus Antigen, Candida albicans Antigen, Saccharomyces Antigen, A. caninum NIF, S. pombe RNA1P, S. pombe RNA; By pathogen type Inactivated Pathogen, Purified Pathogen; By application type Immunohis
A wide range of fungal species of Aspergillus and other fungal organisms play important roles in the pharmacy and healthcare industry. For instance, some of the Aspergillus species play vital roles in commercial microbial fermentations and are also involved in the production of foreign or native enzymes. These fungal species can cause infections in humans.
Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1773
A range of fungal diseases in humans include infections of the ear, external skin wounds and ulcers. Other fungal species also act as raw material sources that can be used to develop medications. Owing to increased applications of fungal antigens to diagnose various fungal infections for clinical research purposes, a large number of local manufacturers have expanded their product portfolio of fungal pathogens intended for academic as well as industrial applications.
Fungal antigens in the fungal antigens market are commercially available in distinct formats, which include purified and inactivated pathogens. A wide range of native state fungal antigens are highly in demand, particularly for in-vitro diagnostics. Standard properties recommended for apt fungal antigens include higher specificity & sensitivity, simple production & quality control and the capability of a fungal antigen to carry out early diagnosis of fungal infection in order to get effective treatment.
Under the product type segment defined for the fungal antigens market, the Aspergillus antigen accounts for a significant revenue share in the global fungal antigens market followed by the Saccharomyces fungal antigen. On the account of their usage as reagents to diagnose fungal diseases, fungal antigens are of great interest. These fungal antigens find applications in various diagnostic techniques, which include Immunohistochemistry (IHC), Polymerase chain reaction (PCR), In-situ hybridization (ISH) and SDS-PAGE in the fungal antigens market.
They also find major applications to carry out immunological tests to diagnose mycotic infections. With the growing incidence of fungal diseases, there is an urgent need to create sensitive, commercially available and reliable tests to diagnose the opportunistic fungal pneumonias. The major potential end users for the fungal antigens market, where these antigens are highly in demand and generate significant revenues, include hospitals, associated diagnostic laboratories, diagnostic laboratories & centres and academic & research institutes.
Request For Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1773
Fungal Antigens Market: Drivers and Restraints
The growing demand for fungal antigens indicated for fungal antigens that are capable of eliciting a protective immune response against various cancers and infectious diseases such as HIV AIDS is expected to be a major factor driving the fungal antigens market over the forecast period. Also, rapid discovery of novel fungal antigens, growing incidence of cancers & infectious diseases and increase in diagnostic population for variant diseases is also expected to drive the revenue growth of the global fungal antigens market.
Also, increasing prevalence of infections caused by fungal pathogens and changing climatic conditions leading to increased incidence of fungal infections is expected to generate revenue opportunities for the fungal antigens market. The approval and launch of new fungal antigens is the other important factor contributing to the growth of the global fungal antigens market. However, increasing risk of adverse reactions with antigens is restraining the revenue growth of the global fungal antigens market.
Fungal Antigens Market: Overview
The global market for fungal antigens is expected to register a moderate growth rate over the forecast period owing to significant investments to introduce innovative tests to capitalise on the opportunities in the untapped market. According to a study conducted by CDC, histoplasmosis is registered as significant infection in patients with HIV and AIDS. Late diagnosis leading to the delayed treatment of the disease can prove fatal, hence, the need for fungal antigens is on rise.
Recently, different types of fungal antigens are being introduced in the fungal antigens market by the leading players, which include Bio-Rad Laboratories, Inc. and Creative Diagnostics. There is high competition among local and regional players in the fungal antigens market. Among the fungal antigens type indicated for various diagnostic applications, the Aspergillus antigen segment is expected to lead the global fungal antigens market over the forecast period.
Diagnostic laboratories and centres are expected to contribute a high revenue share in the global fungal antigens market as they are the most significant platforms to perform diagnostic tests and generate high demand for fungal antigens. Hospital-associated diagnostic laboratories also account for significant revenue generation owing to a large number of patients wanting to get diagnosed.
Fungal Antigens Market: Regional Outlook
Geographically, the global fungal antigens market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is registered as the dominant market player in global fungal antigens market on the account of growing research applications of fungal antigens along with increased set up of advanced diagnostic laboratories in the region as compared to other regions.
The fungal antigens market in Asia Pacific excluding Japan is expected to grow at the highest CAGR due to a strong foothold of domestic players manufacturing fungal antigens. Europe is expected to register the second largest revenue share in the global fungal antigens-market throughout the forecast period owing to the increased presence of distributors and suppliers for fungal antigens across the region.
Report Analysis @ https://www.factmr.com/report/1773/fungal-antigens-market
Fungal Antigens Market: Key Players
The global fungal antigens market is highly fragmented owing to presence of a large number of domestic manufacturers. Examples of some of the key players operating in the global fungal antigens market are Bio-Rad Laboratories, Inc., Creative Diagnostics, IMMY, QED Bioscience Inc., Pulse Scientific Inc. and Jena Bioscience GmbH.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fungal Antigens Market Segmentation By product type Aspergillus Antigen, Candida albicans Antigen, Saccharomyces Antigen, A. caninum NIF, S. pombe RNA1P, S. pombe RNA; By pathogen type Inactivated Pathogen, Purified Pathogen; By application type Immunohis here
News-ID: 1336098 • Views: …
More Releases from Fact.MR
Automatic Pet Feeder Market To Witness Exponential Growth, Expected to Hit US$ 1 …
The market for automatic pet feeders is expected to grow at a strong rate of 9.6% CAGR to reach US$ 1.36 billion by the end of 2032, from its estimated value of US$ 540.8 million in 2022.
By the end of 2021, sales of automatic pet feeders with capacities greater than five liters represented about 45% of the worldwide market for automatic pet feeders.
Download a Sample Copy Of Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5963
Pet owners…
Tomato Powder Market Is Estimated To Reach US$ 2.3 Billion By The End Of 2033: F …
In 2023, the global market for tomato powder reached a valuation of US$ 1.6 billion. Projections indicate that by the close of 2033, sales of tomato powder on a global scale are expected to climb to US$ 2.3 billion, marking a compound annual growth rate (CAGR) of 3.7% from 2023 to 2033.
The Tomato Powder Industry sales study offers a comprehensive analysis on diverse features including production capacities, Tomato Powder demand,…
Portable Video Game Consoles Market Is Projected To Reach US$ 27 Billion By 2033 …
The forecast indicates a steady rise in global demand for portable video game consoles, projecting a Compound Annual Growth Rate (CAGR) of 6% from 2023 to 2033. Presently, the market for portable video game consoles stands at a valuation of US$ 15 billion globally. This figure is poised to ascend to US$ 27 billion by the conclusion of 2033.
The Portable Video Game Consoles Industry sales study offers a comprehensive analysis…
Smart Parking Solutions Market Is Forecasted To Reach US$ 39.2 Billion By 2034: …
Expanding at a CAGR of 20%, the global smart parking solution market size is set to jump from US$ 6.3 billion in 2024 to US$ 39.2 billion by 2034-end, as assessed by Fact.MR and revealed in its updated market report.
The Smart Parking Solution Industry sales study offers a comprehensive analysis on diverse features including production capacities, Smart Parking Solution demand, product developments, sales revenue generation and Smart Parking Solution…
More Releases for Antigens
Viral Antigens market rising at 11.0 % CAGR to 2027
The proposed Viral Antigens market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The Viral Antigens market was valued at US$101.41 million in…
Native Bacterial and Viral Antigens market growing at 6.8 % CAGR to 2027
The proposed Native Bacterial and Viral Antigens market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The native bacterial and viral antigens market…
Bacterial And Viral Antigens Market: Key Players, Growth, Analysis, 2021-2028
An exceptional companion Bacterial And Viral Antigens Market report takes into consideration diverse segments of the market analysis that today's business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the Veterinary Diagnostics industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2022 whereas the historic year is 2019 which…
Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. All of these new products are produced using standardized production processes to ensure the highest quality. Tests developed using these reagents can assist researchers in routine diagnostics and NiV vaccine development.
Nipah virus (NiV) was initially isolated and identified in 1999 during an outbreak…
Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens that are well validated in double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). The newly introduced antigens consist of five of the most common staphylococcus aureus enterotoxins and are ideal for in vitro detection and diagnostic studies.
Staphylococcus aureus is a Gram-positive spherical bacterium about 1…
Viral Antigens Market to Exhibit 9% CAGR through 2030
The advent of advanced therapies and test kits that employ the use of virus components such as antigens has paved way for the treatment several diseases. In recent years, the viral antigens market has been witnessing substantial investments, robust R&D activities and strategic collaborations. In 2018, ACROBiosystems announces collaboration with ProMab Biotechnologies for immunotherapy research using viral antigens for vaccine development and launch of new diagnostic kits.
Acquisition of smaller companies…
